Acne Advanced Cleansing
Salicylic Acid
Eminence Organic Skin Care Ltd.
Human Otc Drug
NDC 15751-3010Acne Advanced Cleansing also known as Salicylic Acid is a human otc drug labeled by 'Eminence Organic Skin Care Ltd.'. National Drug Code (NDC) number for Acne Advanced Cleansing is 15751-3010. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Acne Advanced Cleansing drug includes Salicylic Acid - 10 mg/mL . The currest status of Acne Advanced Cleansing drug is Active.
Drug Information:
| Drug NDC: | 15751-3010 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Acne Advanced Cleansing |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Salicylic Acid |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Eminence Organic Skin Care Ltd. |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Liquid |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | SALICYLIC ACID - 10 mg/mL
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | TOPICAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 01 Sep, 2018 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 22 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part333D |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Eminence Organic Skin Care Ltd.
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 1038982
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | O414PZ4LPZ
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 15751-3010-5 | 1 BOTTLE in 1 BOX (15751-3010-5) / 150 mL in 1 BOTTLE | 01 Sep, 2018 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose acne treatment
Product Elements:
Acne advanced cleansing salicylic acid aloe cucumber rosa moschata oil grapefruit symphytum uplandicum leaf peppermint calendula officinalis flower beta vulgaris glycerin decyl glucoside sodium cocoyl glutamate spearmint caprylyl glycol tocopherol dexpanthenol thyme cinnamon olive oil rosemary cocamidopropyl dimethylamine goldenseal lemon ethylhexylglycerin green tea leaf sodium pyrrolidone carboxylate arbutin acai carrot coconut starch, tapioca thioctic acid ubidecarenone salicylic acid salicylic acid
Indications and Usage:
Use for the treatment of acne.
Warnings:
Warnings for external use only when using this product skin irritation and dryness are more likely to occur when using another topical acne product at the same time. if irritation occurs, use only one product at a time. avoid eye area. in case of eye contact, flush gently and thoroughly with water. keep out of reach of children. if swallowed, get medical help or contact poison control center right away.
When Using:
When using this product skin irritation and dryness are more likely to occur when using another topical acne product at the same time. if irritation occurs, use only one product at a time. avoid eye area. in case of eye contact, flush gently and thoroughly with water.
Dosage and Administration:
Direcitons use 1 to 3 times daily. pump a small amount of product to transform the liquid into a lightweight foam. apply to skin and massage gently with fingertips in a circular motion covering the face and neck. rinse thoroughly and pat dry. because excessive drying of the skin may occur, strar with one application daily, then gradually increase to 2 ot 3 times daily if needed or as directed by a doctor. if bothersome dryness or peeling occurs, reduce application to once a day or every other day.
Package Label Principal Display Panel:
Package labeling for box: label
Package labeling for bottle: bottle